Enterprise AI Private

Aidoc

Always-on AI for radiology

Founded 2016 Tel Aviv, Israel 201-500 employees Series D SaaS subscriptions to hospitals and imaging centers
Funding Status
Series D
Private Company

About Aidoc

Aidoc is an AI-powered radiology platform that runs in the background of medical imaging workflows, continuously analyzing CT, MRI, and X-ray scans to flag critical findings and prioritize urgent cases for radiologists. The platform helps ensure that time-sensitive conditions like intracranial hemorrhages, pulmonary embolisms, and cervical spine fractures are identified and treated as quickly as possible.

Aidoc's AI operates as an 'always-on' assistant that triages imaging studies before a radiologist reviews them, pushing the most critical cases to the top of the reading worklist. This is particularly valuable in emergency settings where thousands of scans queue up and life-threatening findings can be buried in the backlog.

The company has over 20 FDA-cleared AI solutions and is deployed in more than 1,000 medical centers globally, analyzing millions of scans. Aidoc's platform approach — running multiple AI algorithms on a single infrastructure — makes it efficient for hospitals to deploy AI across radiology subspecialties without managing multiple point solutions.

Products & Services

Aidoc aiOS

AI operating system for radiology with multiple FDA-cleared algorithms

Critical Finding Detection

Real-time AI triage for intracranial hemorrhage, PE, and spine fractures

Workflow Orchestration

AI-driven prioritization and routing of imaging studies to radiologists

Leadership

E
Elad Walach
CEO & Co-Founder

Notable Achievements

  • 20+ FDA-cleared AI radiology solutions
  • Deployed in 1,000+ medical centers globally
  • Millions of scans analyzed by AI
  • Always-on triage reduces critical diagnosis delays

NexChron Coverage

Latest articles mentioning Aidoc

No articles yet. Our coverage of Aidoc is expanding.

Financial Disclosure: NexChron provides financial data for informational purposes only. This is not investment advice, a recommendation to buy or sell securities, or an offer to transact. Stock prices are delayed up to 15 minutes and sourced from Yahoo Finance. Funding round data is compiled from public reports and may not reflect the most current information. Company valuations, revenue estimates, and financial projections are based on publicly available data and may be inaccurate or outdated. Always consult a qualified financial advisor before making investment decisions. NexChron, its founder, and contributors may hold positions in companies mentioned on this site.